Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Clarification or more confusion?

....what would the harm be in stating "some licenses included in this quarter have been granted with ongoing royalty payments over a period of time rather than a lump sum payment"?

If each and every settlement or licensing agreement says the terms are confidential then TPL/Alliacense/PTSC could not state "some licenses included in this quarter have been granted with ongoing royalty payments over a period of time rather than a lump sum payment" without violating those terms. Just because a determination cannot be made on which company has agreed to royalty payments does not let any of the parties off the hook wrt their confidentiality obligations. Opinions welcome.

Share
New Message
Please login to post a reply